trientine tetrahydrochloride (as trientine 150 MG) Oral Tablet

RxCUI
2611544
RxNorm name
trientine tetrahydrochloride (as trientine 150 MG) Oral Tablet
Display name
trientine tetrahydrochloride (as trientine 150 MG) Oral Tablet
Full name
trientine tetrahydrochloride (as trientine 150 MG) Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CUVRIORTRIENTINE TETRAHYDROCHLORIDEOrphalan SAf73feeae-62ad-401e-b9f7-5cb2691277502025-06-19Warnings, Adverse reactionsExact identifier
rxcui: 2611544

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f73feeae-62ad-401e-b9f7-5cb269127750trientine tetrahydrochloride (as trientine 150 MG) Oral TabletSY7These highlights do not include all the information needed to use CUVRIOR safely and effectively. See full prescribing information for CUVRIOR. CUVRIOR ® (trientine tetrahydrochloride) tablets, for oral use Initial U.S. Approval: 198520250619
f73feeae-62ad-401e-b9f7-5cb269127750trientine tetrahydrochloride 300 MG Oral TabletPSN7These highlights do not include all the information needed to use CUVRIOR safely and effectively. See full prescribing information for CUVRIOR. CUVRIOR ® (trientine tetrahydrochloride) tablets, for oral use Initial U.S. Approval: 198520250619
f73feeae-62ad-401e-b9f7-5cb269127750trientine tetrahydrochloride 300 MG Oral TabletSCD7These highlights do not include all the information needed to use CUVRIOR safely and effectively. See full prescribing information for CUVRIOR. CUVRIOR ® (trientine tetrahydrochloride) tablets, for oral use Initial U.S. Approval: 198520250619